Redcare Pharmacy NV (HAM:RDC) Dividends Received

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HAM:RDC Redcare Pharmacy NV HAM:RDC
14 GF Score
Price €65.20
GF Value €187.96
Valuation Significantly Undervalued
! 2 Warning Signs
View Full Analysis

What is Redcare Pharmacy NV Dividends Received?

Dividends Received only applicable to companies reporting Cash Flow from Operations in direct method.

HAM:RDC
14GF Score
Redcare Pharmacy NV HAM:RDC
Dividends Received is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Redcare Pharmacy NV (HAM:RDC) Overvalued in 2026?

Based on GuruFocus' analysis, Redcare Pharmacy NV stock appears to be undervalued. The current stock price of €65.20 is trading 65.3% below its estimated GF Value™ of €187.96. GuruFocus considers Redcare Pharmacy NV to be Significantly Undervalued.

Key valuation signals for HAM:RDC:

  • Dividends Received:
  • GF Value™: €187.96 vs. price of €65.20 (65.3% below fair value)
  • GF Score™: 14/100 with 2 warning signs

No single metric tells the full story. See the HAM:RDC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Redcare Pharmacy NV Business Description

Address Erik de Rodeweg 11/13, Sevenum, ZH, NLD, 5975 WD
Redcare Pharmacy NV is an online pharmacy business for prescription and nonprescription (over-the-counter) pharmaceuticals, beauty and personal care products (BPC) and food supplements. Besides OTC, nutritional supplements, beauty and personal care products as well as an extensive assortment of health-related products in all markets, the company also provides prescription drugs for customers in Germany, Switzerland and the Netherlands. It operates in two segments, namely DACH segment that includes sales in Germany, Austria and Switzerland; and the International segment that includes sales across Belgium, the Netherlands, France and Italy. The DACH segment accounts for the majority of the revenue.
14GF Score

Get the complete analysis for HAM:RDC

Dividends Received is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€65.20
Price
€187.96
GF Value